N95 Mask Market Size
The Global N95 Mask Market reached US$ 2.65 billion in 2023 and is expected to reach US$ 5.27 billion by 2031, growing at a CAGR of 9.2% during the forecast period 2024-2031.
An N95 is a type of respirator mask used as personal protective equipment for the prevention of inhaling aerosols as well as vapors or gases that are health hazards. N95 mask also protects against inhaling micro airborne infectious agents such as airborne viruses including coronavirus, SARS, H1N1, etc. According to the European standard, it should have a minimum of 95% filtration and a maximum of 8% leakage to the inside.
N95 masks are gaining popularity as it is considered the most common and best-selling type of respirator mask, for protection against the coronavirus, it is also used in versatile industries such as construction, agriculture, healthcare, metals & mining, and others. In N95, the N stands for "Non-Oil" and indicates that the mask can be used in a work environment without oil-based particulates, the 95 indicates that the mask has a 95% efficiency rate. The 3-micron mask filters out contaminants like specks of dust, mists, and fumes.
Market Summary
| Metrics | Details |
| CAGR | 9.2% |
| Market Size | 2022-2031 |
| Market Estimation Forecast Period | 2024-2031 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Product, Usage, Type, and End-User |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter's Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
For more details on this report - Request for Sample
Market Dynamics: Drivers
Increasing prevalence of infectious and respiratory diseases
The rising prevalence of infectious and respiratory diseases propels the market growth. Infectious diseases such as tuberculosis, pertussis, avian influenza, and adenovirus infections can be prevented by wearing N95 masks. For instance, according to WHO, a total of 1.3 million people died from TB in 2022. Worldwide, TB is the second leading infectious killer after COVID-19 (above HIV and AIDS). In 2022, an estimated 10.6 million people fell ill with tuberculosis (TB) worldwide, including 5.8 million men, 3.5 million women and 1.3 million children. TB is present in all countries and age groups. TB is curable and preventable.
According to cdc.gov, an estimated 11–21 million cases of typhoid fever and 5 million cases of paratyphoid fever occurs worldwide each year, causing an estimated 135,000–230,000 deaths. Approximately 85% of typhoid fever and 92% of paratyphoid fever cases in the United States occur among international travelers; most are travelers returning from South Asia, primarily Bangladesh, India, and Pakistan.
Restraints
Factors such as competition and market saturation, stringent regulatory requirements, supplychain disruptions regarding raw materials are expected to hamper the market.
Market Segment Analysis
The global N95 mask market is segmented based on product, usage, type, end-user, and region.
The segment standard N95 respirator accounted for approximately 34.6% of the global N95 mask market share
The standard N95 respirator segment is expected to hold the largest market share over the forecast period. In this segment, the development of government regulation, and increasing demand would drive this market.
A standard N95 respirator is a respiratory protective device that fits closely to the face and filters airborne particles efficiently. The edges of the respirator are designed to seal around the nose and mouth. Standard N95 respirators are designed to help reduce the wearer’s exposure to airborne particulate hazards. In the U.S., respirators are tested and certified by the U.S. National Institute of Occupational Safety and Health (NIOSH). NIOSH tests and certifies respirators based on their physical and performance characteristics, including filtration efficiency.
Market Geographical Share
North America accounted for approximately 42.6% of the global N95 mask market share
North America region is expected to hold the largest market share over the forecast period. The rising incidence of infectious and respiratory diseases, and growing awareness among people, in this region, help to propel the market.
For instance, according to an article posted by Center for Infectious Disease Research and Policy in March 2024, the number of tuberculosis (TB) cases in the United States climbed in 2023, the third straight year of increases, according to new data from the Centers for Disease Control and Prevention (CDC). The data published showed that 9,615 TB cases were reported in the United States in 2023, a 16% increase from 2022 and the highest number reported since 2013. The TB incidence rate of 2.9 cases per 100,000 persons represented a 15% increase from 2022. TB incidence increased in every age group, with the largest increase seen in children ages 5 to 14 years.
As in previous years, most reported TB cases in 2023 (76%) occurred in non–US-born residents. But case counts rose among both US-born and non–US-born residents, who saw increases of 9% and 18%, respectively. Among US-born persons with TB, 33% were Black, 27% Hispanic, 26% White, 6% Asian, 5% American Indian or Native Alaskan, and 3% Native Hawaiian or other Pacific Islander.
Market Segmentation
By Product
- With Exhalation Valve
- Without Exhalation Valve
By Usage
- Reusable
- Disposable
By Type
- Standard N95 Respirator
- Surgical N95 Respirator
By End-User
- Hospitals
- Mining Industries
- Construction Firms
- Oil & Gas Industries
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
Market Competitive Landscape
The major global players in the global N95 mask market include Shawmut Corporation, 3M, Honeywell, Ambu A/S, Moldex-Metric Inc., Alpha Pro Tech, Ohlone Press LLC, Teleflex, Kimberly-Clark Corporation, and The Gerson Company among others.
Key Developments
- In August 2022, Optrel, a leading manufacturer of respiratory protection, launched the P Air Clear, the world's first NIOSH-approved N95 respirator with a transparent window. Swiss-made with the highest quality material for comfort and function, the P Air Clear features a transparent window, a latex-free head harness, and an adjustable nose clip.
- In April 2022, RB Sigma announced that its domestically manufactured N95 Filtering Facepiece Respirator was approved by the National Institute for Occupational Safety and Health (NIOSH).
Why Purchase the Report?
- To visualize the global N95 mask market segmentation based on product, usage, type, end-user, and region, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development
- Excel data sheet with numerous data points of global N95 mask market level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping is available in Excel consisting of key products of all the major players.
The global N95 mask market report would provide approximately 51 tables, 54 figures, and 181 Pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
